HomeCompareANONX vs JNJ

ANONX vs JNJ: Dividend Comparison 2026

ANONX yields 7.42% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ANONX wins by $12.7K in total portfolio value
10 years
ANONX
ANONX
● Live price
7.42%
Share price
$22.24
Annual div
$1.65
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.7K
Annual income
$1,188.35
Full ANONX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ANONX vs JNJ

📍 ANONX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodANONXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ANONX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ANONX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ANONX
Annual income on $10K today (after 15% tax)
$630.89/yr
After 10yr DRIP, annual income (after tax)
$1,010.10/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ANONX beats the other by $306.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ANONX + JNJ for your $10,000?

ANONX: 50%JNJ: 50%
100% JNJ50/50100% ANONX
Portfolio after 10yr
$26.4K
Annual income
$1,008.07/yr
Blended yield
3.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ANONX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ANONX buys
0
JNJ buys
0
No recent congressional trades found for ANONX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricANONXJNJ
Forward yield7.42%3.36%
Annual dividend / share$1.65$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$32.7K$20.0K
Annual income after 10y$1,188.35$827.78
Total dividends collected$9.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ANONX vs JNJ ($10,000, DRIP)

YearANONX PortfolioANONX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,442$742.22$10,676$355.77+$766.00ANONX
2$13,037$793.71$11,407$389.39+$1.6KANONX
3$14,795$845.16$12,198$426.53+$2.6KANONX
4$16,727$896.37$13,056$467.62+$3.7KANONX
5$18,845$947.12$13,987$513.12+$4.9KANONX
6$21,161$997.24$14,998$563.56+$6.2KANONX
7$23,689$1,046.57$16,098$619.52+$7.6KANONX
8$26,442$1,094.94$17,295$681.69+$9.1KANONX
9$29,435$1,142.24$18,599$750.82+$10.8KANONX
10$32,684$1,188.35$20,022$827.78+$12.7KANONX

ANONX vs JNJ: Complete Analysis 2026

ANONXStock

Under normal market conditions, the fund invests at least 80% of its net assets in small cap companies. The portfolio managers consider small cap companies to include those with a market capitalization that does not exceed that of the largest company in the Russell 2000 Growth Index. The portfolio managers look for stocks of smaller-sized companies they believe will increase in value over time, using an investment strategy developed by the fund's investment advisor.

Full ANONX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ANONX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ANONX vs SCHDANONX vs JEPIANONX vs OANONX vs KOANONX vs MAINANONX vs ABBVANONX vs MRKANONX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.